Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT00191295 · COMPLETED
Trial details
- NCT number
- NCT00191295
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.